Authors:
Klungel, OH
Leufkens, HGM
de Boer, A
Longstreth, WT
Kaplan, RC
Smith, NL
Psaty, BM
Citation: Oh. Klungel et al., Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs - In reply, ARCH IN MED, 161(17), 2001, pp. 2153-2153
Authors:
Heckbert, SR
Kaplan, RC
Weiss, NS
Psaty, BM
Lin, DY
Furberg, CD
Starr, JR
Anderson, GD
LaCroix, AZ
Citation: Sr. Heckbert et al., Risk of recurrent coronary events in relation to use and recent initiationof postmenopausal hormone therapy, ARCH IN MED, 161(14), 2001, pp. 1709-1713
Authors:
Rea, TD
Heckbert, SR
Kaplan, RC
Psaty, BM
Smith, NL
Lemaitre, RN
Lin, D
Citation: Td. Rea et al., Body mass index and the risk of recurrent coronary events following acute myocardial infarction, AM J CARD, 88(5), 2001, pp. 467-472
Authors:
Klungel, OH
Kaplan, RC
Heckbert, SR
Smith, NL
Lemaitre, RN
Longstreth, WT
Leufkens, HGM
de Boer, A
Psaty, BM
Citation: Oh. Klungel et al., Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients, STROKE, 31(2), 2000, pp. 420-424
Citation: Rc. Kaplan et al., Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding, ARCH IN MED, 160(12), 2000, pp. 1849-1855
Authors:
Dublin, S
Lydon-Rochelle, M
Kaplan, RC
Watts, DH
Critchlow, CW
Citation: S. Dublin et al., Maternal and neonatal outcomes after induction of labor without an identified indication, AM J OBST G, 183(4), 2000, pp. 986-994
Authors:
Psaty, BM
Weiss, NS
Furberg, CD
Koepsell, TD
Siscovick, DS
Rosendaal, FR
Smith, NL
Heckbert, SR
Kaplan, RC
Lin, DY
Fleming, TR
Wagner, EH
Citation: Bm. Psaty et al., Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease, J AM MED A, 282(8), 1999, pp. 786-790
Citation: Rc. Kaplan et al., Blood pressure level and incidence of myocardial infarction among patientstreated for hypertension, AM J PUB HE, 89(9), 1999, pp. 1414-1417